MedTrace Logo

Repetitive Transcranial Magnetic Stimulation Trajectory of Outcomes Study

NCT04376697 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2020-12-29

No results posted yet for this study

Summary

This prospective, single-arm, open-label feasibility study will assess the safety, tolerability, and effectiveness of repetitive transcranial magnetic stimulation (rTMS) in patients with major depression (MDD) to test the hypothesis that remission rates can be increased by additional treatment sessions.

Conditions

  • Depressive Disorder

Interventions

DEVICE

Repetitive Transcranial Magnetic Stimulation (rTMS)

The treatment will be delivered by trained medical personnel.

Sponsors & Collaborators

  • Centre for Addiction and Mental Health

    collaborator OTHER

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Jonathan Downar · University Health Network, Toronto

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-18
Primary Completion
2020-12-31
Completion
2021-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04376697 on ClinicalTrials.gov